Matias-Guiu X, Peiro G, Esquius J, Oliva E, Cabezas R, Colomer A, Prat J
Department of Pathology, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Spain.
Pathol Res Pract. 1995 Feb;191(1):42-7. doi: 10.1016/S0344-0338(11)80921-0.
C cell hyperplasia (CCH) is a preneoplastic lesion that precedes the development of medullary thyroid carcinoma (MTC) in familial cases. It has been hypothesized that CCH progressively acquires the neoplastic phenotype after presenting some genetic changes that involve oncogenes and tumor suppressor genes. The proliferative activity of nodular C cell hyperplasia (NCCH) and early MTC has been assessed by PCNA (Proliferating Cell Nuclear Antigen) immunohistochemistry and nucleolar organizer regions silver staining (AgNOR) in surgical specimens of seven patients with familial MTC. The ratios of PCNA-positive nuclei in NCCH (mean 1.2, range 0.2-4) were lower than in MTC (mean 2, range 1-7%). The AgNOR scores for NCCH (mean 1.53, range 1.10-1.90) were also lower than for MTC (mean 2.10, range 1.90-2.64). The results suggest that C cells progressively acquire a higher proliferative activity in agreement with the severity of the morphologic changes in the process of hyperplasia-neoplasia that leads to widely invasive MTC.
C细胞增生(CCH)是一种癌前病变,在家族性病例中先于甲状腺髓样癌(MTC)出现。据推测,CCH在出现一些涉及癌基因和肿瘤抑制基因的基因变化后,逐渐获得肿瘤表型。通过对7例家族性MTC患者手术标本进行增殖细胞核抗原(PCNA)免疫组化和核仁组织区银染(AgNOR),评估了结节性C细胞增生(NCCH)和早期MTC的增殖活性。NCCH中PCNA阳性细胞核的比例(平均1.2,范围0.2 - 4)低于MTC(平均2,范围1 - 7%)。NCCH的AgNOR评分(平均1.53,范围1.10 - 1.90)也低于MTC(平均2.10,范围1.90 - 2.64)。结果表明,C细胞在增生 - 肿瘤形成过程中,随着形态学变化的严重程度逐渐获得更高的增殖活性,这种变化会导致具有广泛侵袭性的MTC。